Review: could Januvia cause Colon cancer?
Summary: Colon cancer is found among people who take Januvia, especially for people who are male, 60+ old, have been taking the drug for 1 - 2 years, also take medication Zocor, and have Type 2 diabetes.
We study 19,165 people who have side effects while taking Januvia from FDA and social media. Among them, 15 have Colon cancer. Find out below who they are, when they have Colon cancer and more.
You are not alone: join a mobile support group for people who take Januvia and have Colon cancer >>>
Januvia has active ingredients of sitagliptin phosphate. It is often used in diabetes. (latest outcomes from 19,562 Januvia users)
Colon cancer has been reported by people with rheumatoid arthritis, multiple sclerosis, high blood pressure, osteoporosis, preventive health care. (latest reports from 20,071 Colon cancer patients)
On Feb, 4, 2015: 19,159 people reported to have side effects when taking Januvia. Among them, 15 people (0.08%) have Colon Cancer.
Time on Januvia when people have Colon cancer * :
|< 1 month||1 - 6 months||6 - 12 months||1 - 2 years||2 - 5 years||5 - 10 years||10+ years |
|Colon cancer||0.00%||37.50%||25.00%||37.50%||0.00%||0.00%||0.00% |
Gender of people who have Colon cancer when taking Januvia * :
|Colon cancer||42.86%||57.14% |
Age of people who have Colon cancer when taking Januvia * :
|Colon cancer||0.00%||0.00%||0.00%||0.00%||0.00%||0.00%||14.29%||85.71% |
Severity of Colon cancer when taking Januvia ** :
How people recovered from Colon cancer ** :
Top conditions involved for these people * :
- Type 2 diabetes mellitus (12 people, 80.00%)
- Hypertension (7 people, 46.67%)
- Dyslipidaemia (5 people, 33.33%)
- Diabetes mellitus (3 people, 20.00%)
- Pain (1 people, 6.67%)
Top co-used drugs for these people * :
- Zocor (6 people, 40.00%)
- Metformin pamoate (5 people, 33.33%)
- Eprosartan mesylate (5 people, 33.33%)
- Janumet (5 people, 33.33%)
- Metformin (4 people, 26.67%)
* Approximation only. Some reports may have incomplete information.
** Reports from social media are used.
How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.
Do you have Colon Cancer while taking Januvia?
You are not alone! Join a mobile support group:
- support group for people who take Januvia and have Colon Cancer
- support group for people who take Januvia
- support group for people who have Colon Cancer
Drugs in real world that are associated with:
Could your condition cause:
Can you answer these questions (Ask a question):
More questions for: Januvia, Colon cancer
More reviews for: Januvia, Colon cancer
Comments from related studies:
From this study (1 week ago):
Severe left back of thigh pain upon bending over or walking
From this study (3 weeks ago):
fecal incontinence only while sleeping
From this study (4 weeks ago):
Eye twitches but not all the time
Post a new comment OR Read more comments
NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.